1. Home
  2. VOR vs SKYX Comparison

VOR vs SKYX Comparison

Compare VOR & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOR
  • SKYX
  • Stock Information
  • Founded
  • VOR 2015
  • SKYX 2004
  • Country
  • VOR United States
  • SKYX United States
  • Employees
  • VOR N/A
  • SKYX N/A
  • Industry
  • VOR Biotechnology: Pharmaceutical Preparations
  • SKYX Building Products
  • Sector
  • VOR Health Care
  • SKYX Consumer Discretionary
  • Exchange
  • VOR Nasdaq
  • SKYX Nasdaq
  • Market Cap
  • VOR 85.7M
  • SKYX 99.2M
  • IPO Year
  • VOR 2021
  • SKYX 2022
  • Fundamental
  • Price
  • VOR $0.16
  • SKYX $1.34
  • Analyst Decision
  • VOR Strong Buy
  • SKYX Strong Buy
  • Analyst Count
  • VOR 7
  • SKYX 2
  • Target Price
  • VOR $9.43
  • SKYX $3.50
  • AVG Volume (30 Days)
  • VOR 943.4K
  • SKYX 310.3K
  • Earning Date
  • VOR 05-16-2025
  • SKYX 05-16-2025
  • Dividend Yield
  • VOR N/A
  • SKYX N/A
  • EPS Growth
  • VOR N/A
  • SKYX N/A
  • EPS
  • VOR N/A
  • SKYX N/A
  • Revenue
  • VOR N/A
  • SKYX $86,276,876.00
  • Revenue This Year
  • VOR N/A
  • SKYX $23.10
  • Revenue Next Year
  • VOR N/A
  • SKYX $27.44
  • P/E Ratio
  • VOR N/A
  • SKYX N/A
  • Revenue Growth
  • VOR N/A
  • SKYX 46.77
  • 52 Week Low
  • VOR $0.15
  • SKYX $0.75
  • 52 Week High
  • VOR $1.87
  • SKYX $2.14
  • Technical
  • Relative Strength Index (RSI)
  • VOR 14.74
  • SKYX 60.02
  • Support Level
  • VOR $0.65
  • SKYX $1.23
  • Resistance Level
  • VOR $0.85
  • SKYX $1.43
  • Average True Range (ATR)
  • VOR 0.07
  • SKYX 0.11
  • MACD
  • VOR -0.03
  • SKYX 0.03
  • Stochastic Oscillator
  • VOR 1.88
  • SKYX 79.07

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

About SKYX SKYX Platforms Corp.

SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.

Share on Social Networks: